BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6572988)

  • 1. Response to dexamethasone in psychotic depression.
    Caroff S; Winokur A; Rieger W; Schweizer E; Amsterdam J
    Psychiatry Res; 1983 Jan; 8(1):59-64. PubMed ID: 6572988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic depression and mortality.
    Vythilingam M; Chen J; Bremner JD; Mazure CM; Maciejewski PK; Nelson JC
    Am J Psychiatry; 2003 Mar; 160(3):574-6. PubMed ID: 12611843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.
    Rothschild AJ; Benes F; Hebben N; Woods B; Luciana M; Bakanas E; Samson JA; Schatzberg AF
    Biol Psychiatry; 1989 Oct; 26(6):565-75. PubMed ID: 2790096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol activity and cognitive changes in psychotic major depression.
    Belanoff JK; Kalehzan M; Sund B; Fleming Ficek SK; Schatzberg AF
    Am J Psychiatry; 2001 Oct; 158(10):1612-6. PubMed ID: 11578992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.
    Hubain PP; Simonnet MP; Mendlewicz J
    Neuropsychobiology; 1986; 16(2-3):57-60. PubMed ID: 3587576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of plasma HVA response to dexamethasone in psychotic depression.
    Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D
    Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early and delayed inpatient dexamethasone suppression tests.
    Haskett RF; Zis AP; Albala AA; Lohr NE; Carroll BJ
    Psychiatry Res; 1989 Feb; 27(2):161-71. PubMed ID: 2710864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients.
    Pfeffer CR; Stokes P; Weiner A; Shindledecker R; Faughnan L; Mintz M; Stoll PM; Heiligenstein E
    Biol Psychiatry; 1989 Nov; 26(7):677-89. PubMed ID: 2804189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
    Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.